[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635991":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":36,"responsibleParty":53,"collaborators":26,"id":55,"slug":26,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":26,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":26,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":39,"whyStopped":26,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Jiangxi Provincial Cancer Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental intervention","EXPERIMENTAL","Topical 2% chlorhexidine spray once daily after showering, sprayed evenly over the entire radiation field from a distance of 15-20 cm, starting 1 day before radiotherapy and continuing until 1 week after radiotherapy; stopped when grade ≥2 acute radiation dermatitis occurs. Standard skin care and health education will also be provided.",[13],"Drug: 2% chlorhexidine",{"label":15,"type":16,"description":17,"interventionNames":18},"Control intervention","PLACEBO_COMPARATOR","Topical sterile water spray with identical appearance and administration schedule, plus the same standard skin care and health education.",[19],"Drug: Sterile Water as control",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","2% chlorhexidine","Topical 2% chlorhexidine spray",[9],null,{"type":22,"name":28,"description":17,"armGroupLabels":29,"otherNames":26},"Sterile Water as control",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},"Tianzhu Lu, PhD","CONTACT","+8615270186250","lutianzhu2008@163.com",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Jiangxi Cancer Hospital","RECRUITING","Nanchang","Jiangxi","330029","China",{"type":45,"coordinates":46},"Point",[47,48],115.85306,28.68396,{"lat":48,"lon":47},[51],{"name":32,"role":33,"phone":52,"phoneExt":26,"email":35},"15270186250",{"type":54,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100635991",false,"NCT07559877","Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:","Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma: A Phase III Randomized Double-Blind Single-Center Trial","Inclusion Criteria:\n\nHistologically or cytologically confirmed nasopharyngeal carcinoma. Clinical stage II-III disease with N≥1, according to the UICC\u002FAJCC 9th edition. Planned to receive first-course definitive chemoradiotherapy, with a total radiotherapy dose of 60-70 Gy.\n\nAble to communicate and complete study assessments. Willing to participate and able to provide written informed consent. Eligible based on baseline assessments performed before chemoradiotherapy.\n\nExclusion Criteria:\n\n* History of or current psychiatric disorder, cognitive impairment, or other severe organic disease.\n\nPresence of another concomitant malignancy. Receipt of any other prophylactic intervention for radiation dermatitis. Pre-existing skin disease before chemoradiotherapy. Known hypersensitivity or allergy to chlorhexidine.","ALL","18 Years","75 Years",{"count":65,"type":66},148,"ESTIMATED","INTERVENTIONAL",[69],"PHASE3","This study investigated the effects of topical chlorhexidine spray on the incidence, severity, and quality of life during radiotherapy in nasopharyngeal carcinoma patients.",[72],"Nasopharangeal Cancer",[74,75,76],"Radiation Dermatitis Acute","Nasoharyngeal carcinoma","chlorhexidine","2026-04-23",{"date":79,"type":80},"2026-04-30","ACTUAL",{"date":82,"type":66},"2026-04-01",{"date":84,"type":66},"2027-09-30",{"name":5,"class":6},1]